<DOC>
	<DOC>NCT00841919</DOC>
	<brief_summary>The purpose of this study is to determine if by using insulin analog (Glargine and lispro insulin) with an insulin pen the investigators are able to obtain a higher rate of correct timing of insulin and food administration as when compared to the usual therapy (insulin NPH and regular) with syringes.</brief_summary>
	<brief_title>Insulin Therapy in the Hospital Comparing Two Protocols</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<criteria>Uncontrolled blood sugar: Random blood sugar â‰¥ 200mg/dl Preprandial blood sugar greater than 180 mg/dl on two occasions within 24 hours. Patient may be off insulin or on subcutaneous inpatient insulin regimen less than 36 hours. Transition from an Insulin Drip in the intensive care units to subcutaneous insulin upon transfer to general ward. Patient is able to eat and oral feeding is expected. Patients receiving inpatient oral hypoglycemic agents Patients with chronic kidney disease stages 4 &amp; 5 (estimated GFR of &lt;30ml/min) and on dialysis Patient with chronic liver disease Patient with hypoglycemia unawareness Pregnancy Patients who are on "NPO" for medical reasons. Patient is expected to stay in the hospital for less than 3 days. Patient on a new inpatient insulin regimen for &gt; 36 hours.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Inpatient</keyword>
	<keyword>Insulin</keyword>
	<keyword>Insulin pen</keyword>
</DOC>